NVIDIA stock forecast 2027–2031
Analysts' average 12-month price target for NVIDIA is 339.17, 69.3% above the current price of 200.28. Their targets range from 210.00 to 515.00.
Of the 32 firms that rated NVIDIA in the past 12 months, 31 rate it buy or strong buy, 1 hold and 0 sell or strong sell (each firm at its latest rating); on average they come to Buy.
Analysts' 1-year price targets range from 210.00 to 515.00, with an average of 339.17.
| Strong buy | 2 | |
| Buy | 29 | |
| Hold | 1 | |
| Sell | 0 | |
| Strong sell | 0 |
12-month price target
| Highest target | 515.00 |
| Average target | 339.17 |
| Lowest target | 210.00 |
| Current price | 200.28 |
NVIDIA price target history
Have analysts recently raised or lowered their NVIDIA price target and rating?
How analysts rate NVIDIA, month by month
31 of 32 firms rate it buy now, against 34 of 35 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
NVIDIA analyst upgrades, downgrades and price targets
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 5 Oct 2026 | BNP Paribas | — | 345.00 | — | 237.11 |
| 2 Oct 2026 | Morgan Stanley | — | 300.00 → 230.00 | -23.3% | 230.86 |
| 2 Oct 2026 | Wells Fargo | — | 315.00 → 210.00 | -33.3% | 230.86 |
| 9 Sept 2026 | Piper Sandler | — | 300.00 | — | 223.67 |
| 27 Aug 2026 | Truist Financial | Reiterated · Buy | 307.00 → 346.00 | +12.7% | 225.98 |
| 27 Aug 2026 | D.A. Davidson Gil Luria | — | 335.00 → 300.00 | -10.4% | 225.64 |
| 27 Aug 2026 | RBC Capital | Reiterated · Outperform | 300.00 → 330.00 | +10.0% | 225.53 |
| 27 Aug 2026 | Needham Quinn Bolton | Reiterated · Buy | 270.00 → 300.00 | +11.1% | 224.71 |
| 27 Aug 2026 | Evercore ISI Mark Lipacis | Reiterated · Outperform | 413.00 → 465.00 | +12.6% | 209.66 |
| 27 Aug 2026 | Raymond James | Reiterated · Strong Buy | 352.00 → 515.00 | +46.3% | 209.66 |
| 27 Aug 2026 | UBS | Reiterated · Buy | 280.00 → 300.00 | +7.1% | 209.66 |
| 27 Aug 2026 | Morgan Stanley | Reiterated · Overweight | 288.00 → 300.00 | +4.2% | 209.66 |
| 27 Aug 2026 | Oppenheimer | Reiterated · Outperform | 265.00 → 315.00 | +18.9% | 209.66 |
| 27 Aug 2026 | Stifel Nicolaus Ruben Roy | — | 282.00 → 315.00 | +11.7% | 209.66 |
| 27 Aug 2026 | Rosenblatt Securities Kevin Cassidy | Reiterated · Buy | 390.00 | — | 209.66 |
| 27 Aug 2026 | Bernstein | Reiterated · Outperform | 275.00 → 400.00 | +45.5% | 209.66 |
| 27 Aug 2026 | Goldman Sachs James Schneider | — | 285.00 → 300.00 | +5.3% | 209.66 |
| 27 Aug 2026 | Melius Research Ben Reitzes | — | 400.00 → 420.00 | +5.0% | 209.66 |
| 27 Aug 2026 | Mizuho Securities Vijay Rakesh | Reiterated · Outperform | 300.00 → 315.00 | +5.0% | 209.66 |
| 27 Aug 2026 | Macquarie | — | 320.00 | — | 209.66 |
| 25 Aug 2026 | Raymond James | Reiterated · Strong Buy | 330.00 → 352.00 | +6.7% | 208.48 |
| 21 Aug 2026 | D.A. Davidson | — | 250.00 → 335.00 | +34.0% | 214.95 |
| 20 Aug 2026 | BMO Capital | — | 340.00 | — | 216.85 |
| 20 Aug 2026 | Oppenheimer Rick Schafer | — | 225.00 → 265.00 | +17.8% | 218.18 |
| 20 Aug 2026 | RBC Capital Srini Pajjuri | Reiterated · Outperform | 280.00 → 300.00 | +7.1% | 217.65 |
| 14 Jul 2026 | KeyBanc John Vinh | Reiterated · Overweight | 310.00 → 330.00 | +6.5% | 203.53 |
| 27 May 2026 | Tigress Financial | Reiterated · Strong Buy | 360.00 → 425.00 | +18.1% | 210.24 |
| 21 May 2026 | Truist Financial | Reiterated · Buy | 275.00 → 307.00 | +11.6% | 219.71 |
| 21 May 2026 | Wedbush | Reiterated · Outperform | 300.00 → 330.00 | +10.0% | 223.47 |
| 21 May 2026 | Argus Research Jim Kelleher | — | 270.00 | — | 224.01 |
| 21 May 2026 | Goldman Sachs | — | 250.00 → 285.00 | +14.0% | 223.47 |
| 21 May 2026 | UBS | Reiterated · Buy | 275.00 → 280.00 | +1.8% | 223.47 |
| 21 May 2026 | Robert W. Baird | — | 300.00 → 500.00 | +66.7% | 223.47 |
| 21 May 2026 | Evercore ISI Mark Lipacis | Reiterated · Outperform | 352.00 → 413.00 | +17.3% | 223.47 |
| 21 May 2026 | Needham Rajvindra Gill | Reiterated · Buy | 200.00 → 270.00 | +35.0% | 223.47 |
| 21 May 2026 | Melius Research Ben Reitzes | — | 300.00 → 400.00 | +33.3% | 223.47 |
| 21 May 2026 | KeyBanc John Vinh | Reiterated · Overweight | 300.00 → 310.00 | +3.3% | 223.47 |
| 21 May 2026 | RBC Capital | Reiterated · Outperform | 270.00 → 280.00 | +3.7% | 223.47 |
| 21 May 2026 | RBC Capital Srini Pajjuri | — | 315.00 → 270.00 | -14.3% | 223.47 |
| 21 May 2026 | RBC Capital | — | 250.00 → 315.00 | +26.0% | 223.47 |
| 21 May 2026 | Morgan Stanley Joseph Moore | Reiterated · Overweight | 285.00 → 288.00 | +1.1% | 223.47 |
| 21 May 2026 | Wolfe Research Chris Caso | — | 230.00 → 275.00 | +19.6% | 223.47 |
| 21 May 2026 | Raymond James Simon Leopold | — | 272.00 → 330.00 | +21.3% | 223.47 |
| 21 May 2026 | Stifel Nicolaus Ruben Roy | Reiterated · Buy | 250.00 → 282.00 | +12.8% | 223.47 |
| 21 May 2026 | Mizuho Securities Vijay Rakesh | — | 275.00 → 300.00 | +9.1% | 223.47 |
| 19 May 2026 | HSBC Frank Lee | Reiterated · Buy | 310.00 → 325.00 | +4.8% | 222.32 |
| 18 May 2026 | Morgan Stanley Joseph Moore | Reiterated · Overweight | 260.00 → 285.00 | +9.6% | 225.32 |
| 18 May 2026 | KeyBanc | Reiterated · Overweight | 275.00 → 300.00 | +9.1% | 225.32 |
| 14 May 2026 | UBS | Reiterated · Buy | 400.00 → 275.00 | -31.3% | 231.27 |
| 14 May 2026 | Cantor Fitzgerald | Reiterated · Overweight | 300.00 → 350.00 | +16.7% | 225.83 |
NVIDIA EPS and revenue estimates
Analysts expect NVIDIA's EPS to grow 63.4% a year until 2029, slower than over the last 5 years (95.9% a year) and the last 3 years (206.6%).
Analysts expect NVIDIA's revenue to grow 62.4% a year until 2029, slower than over the last 5 years (66.9% a year) and the last 3 years (100.0%).
Revenue
EPS
Does NVIDIA beat earnings estimates?
On average, analysts' EPS estimate was 7.7% off the result, either way, and their revenue estimate 4.8%, over the last 12 quarters.
- EPS beats
- 42 / 109
- Revenue beats
- 88 / 109
- Average EPS surprise, last 12
- +7.7%
- Since
- May 1999
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q2 FY2027 | 26 Aug 2026 | 2.09 | 2.22 | +6.2% | 92.27B | 96.22B | +4.3% |
| Q1 FY2027 | 20 May 2026 | 1.76 | 1.87 | +6.3% | 78.42B | 81.62B | +4.1% |
| Q4 FY2026 | 25 Feb 2026 | 1.54 | 1.62 | +5.2% | 66.13B | 68.13B | +3.0% |
| Q3 FY2026 | 19 Nov 2025 | 1.26 | 1.30 | +3.2% | 54.96B | 57.01B | +3.7% |
| Q2 FY2026 | 27 Aug 2025 | 1.01 | 1.05 | +4.0% | 46.05B | 46.74B | +1.5% |
| Q1 FY2026 | 28 May 2025 | 0.74 | 0.81 | +9.9% | 43.33B | 44.06B | +1.7% |
| Q4 FY2025 | 26 Feb 2025 | 0.85 | 0.89 | +5.0% | 38.10B | 39.33B | +3.2% |
| Q3 FY2025 | 20 Nov 2024 | 0.75 | 0.81 | +8.0% | 33.17B | 35.10B | +5.8% |
| Q2 FY2025 | 28 Aug 2024 | 0.65 | 0.68 | +5.4% | 28.78B | 30.04B | +4.4% |
| Q1 FY2025 | 22 May 2024 | 0.56 | 0.61 | +8.9% | 24.59B | 26.04B | +5.9% |
| Q4 FY2024 | 21 Feb 2024 | 0.46 | 0.52 | +13.0% | 20.24B | 22.10B | +9.2% |
| Q3 FY2024 | 21 Nov 2023 | 0.34 | 0.40 | +17.6% | 16.29B | 18.12B | +11.2% |
NVIDIA stock price 2027–2031: scenarios
If NVIDIA's earnings keep growing at the 64.8% a year analysts expect to FY2029, it would earn about 58.02 a share in FY2031. At the P/E it has traded at over the last five years (37.8 to 106.4) that is 2,194.51 to 6,175.86 a share, or 3,464.50 at its average P/E of 59.7. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2027 | 9.29 | 351.40 | 554.77 | 988.93 |
| FY2028 | 15.81 | 597.90 | 943.92 | 1,682.64 |
| FY2029 | 21.38 | 808.50 | 1,276.39 | 2,275.30 |
| FY2030 (extrapolated) | 35.22 | 1,332.01 | 2,102.86 | 3,748.59 |
| FY2031 (extrapolated) | 58.02 | 2,194.51 | 3,464.50 | 6,175.86 |
Each year's EPS is the analysts' consensus to FY2029; the years after continue its 64.8% a year. Bear, base and bull apply the lowest, average and highest P/E of the last five fiscal year ends (37.8, 59.7, 106.4).
Is NVIDIA stock undervalued or overvalued?
NVIDIA's P/E of 25.2 is near the bottom of its 5-year range (25.2 to 245.6, median 55.9). It is within 5% of its 5-year low. Analysts expect slower growth than in recent years, so the low P/E may be deserved. Buyers pay less for each point of growth than usual: a PEG of 0.4 on expected growth against 0.6 on its median P/E and past five years' growth. Growing 63.4% a year, NVIDIA earns a P/E of 25.0 at a PEG of 1 (at most 25): × the next twelve months' EPS of 14.36, a fair value of 359.04; the price, 200.28, is 44.2% below it. Its forward P/E, on the consensus for FY2027, is 21.6.
Fair value on growth is a P/E equal to the EPS growth analysts expect a year (a PEG of 1, at most 25) times the earnings per share of the next twelve months; the ends of the bar are a PEG of 0.75 and 1.25 (a P/E of 18.8 and 31.3). The price against its P/E range
- Price to earnings ratio (TTM)
- 25.19
- Five-year median P/E
- 55.87
- Five-year P/E range
- 25.2 – 245.6
- Forward P/E (FY2027)
- 21.56
- PEG ratio
- 0.39
- To the average target
- +69.3%
Most undervalued US stocks
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 66.390 | 128.2462Price 66.39185 | +93.2% | |
| 101.860 | 195.27146Price 101.86244 | +91.7% | |
| 123.790 | 235.44177Price 123.79294 | +90.2% | |
| 227.150 | 406.28305Price 227.15508 | +78.9% | |
| 159.100 | 284.37213Price 159.10355 | +78.7% | |
| 105.320 | 175.76132Price 105.32220 | +66.9% |
Furthest below the fair value on each stock's page, updated every day.
